Hepatitis C treatment gets political in Spain
This article was originally published in Scrip
Executive Summary
Access to medicines is an increasingly politicized issue and companies will be watching how cash strapped governments respond to mounting pressure to provide patients with their expensive drugs. Ahead of this year's general election, the Spanish health ministry is trying to appease angry hepatitis C patients/voters amid counter calls and pledges from the opposition to take increasingly drastic action to make sure patients get the medicines they need.
You may also be interested in...
Germany Confirms No Reimbursement Status For ‘Lifestyle’ Drug Wegovy
In Germany Novo Nordisk’s obesity drug Wegovy will remain excluded from reimbursement for obesity, unlike Rhythm’s Imcivree.
New HTA Evidence Guidelines In EU Could Spell Trouble For Advanced Therapy Companies
New guidelines that cast doubt over use of single-arm and non-randomized studies are “discouraging” for rare disease patients and the advanced therapy sector, says ARM, the Alliance for Regenerative Medicines.
Germany Courts Clinical Trials With Regulator Reshuffle & New Federal Ethics Committee
Plans to rejig two regulators’ roles and streamline the ethics committee system have drawn some criticism.